医学
危险系数
卡铂
彭布罗利珠单抗
内科学
子宫内膜癌
队列
肿瘤科
安慰剂
化疗
癌症
外科
置信区间
病理
顺铂
替代医学
免疫疗法
作者
Ramez N. Eskander,Michael W. Sill,Lindsey Beffa,Richard G. Moore,Joanie M. Hope,Fernanda Musa,Robert S. Mannel,Mark S. Shahin,Guilherme Cantuaria,Eugenia Girda,Cara Mathews,Juraj Kavecansky,Charles A. Leath,Lilian T. Gien,Emily Hinchcliff,Shashikant Lele,Lisa M. Landrum,Floor Backes,Roisin E. O’Cearbhaill,Tareq Al Baghdadi
标识
DOI：10.1056/nejmoa2302312
摘要
In patients with advanced or recurrent endometrial cancer, the addition of pembrolizumab to standard chemotherapy resulted in significantly longer progression-free survival than with chemotherapy alone. (Funded by the National Cancer Institute and others; NRG-GY018 ClinicalTrials.gov number, NCT03914612.).
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
大力的灵雁
识字岭的岭
蓝莓橘子酱
eric888
tiptip
Neko
penxyy
无极微光
子车茗
GingerF
清欢
BowieHuang
Criminology34
Dean
嘉心糖
bjbmtxy
伯克利芙蓉王
苦咖啡
Singularity
ZOE
皖公网安备34019202002308
